World's Best Scientists 2026 revealed!
Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
143
Citations
75347
World Ranking
1512
National Ranking
47

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award
  • 2020 - Fellow, National Academy of Inventors

Overview

Martin E. Gleave is affiliated with the University of British Columbia in Canada and specializes primarily in medical and biochemistry-related fields. Their research portfolio spans Medicine and Biochemistry, Genetics, and Molecular Biology, with significant contributions to subfields including Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology, and Radiology, Nuclear Medicine and Imaging.

Their academic work extensively focuses on prostate cancer, covering areas such as treatment and research, diagnosis and treatment, as well as cancer-related metabolism and genetics. The main topics of their research output include:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Radiopharmaceutical Chemistry and Applications
  • Ubiquitin and Proteasome Pathways
  • Cancer Genomics and Diagnostics
  • RNA Research and Splicing

Martin E. Gleave has published frequently in a number of journals, with the highest number of publications appearing in:

  • Journal of Clinical Oncology
  • Cancer Research
  • The Journal of Urology
  • European Urology
  • bioRxiv (Cold Spring Harbor Laboratory)

Their recent scholarly articles include:

  • Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery, 2020, ACS Central Science
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019, 2020, European Urology
  • The DNA methylation landscape of advanced prostate cancer, 2020, Nature Genetics
  • Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer, 2023, New England Journal of Medicine
  • Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer, 2022, Nature

Among collaborators, the frequent co-authors of Martin E. Gleave include:

  • Ladan Fazli
  • Neal D. Shore
  • Felix Y. Feng
  • Eric J. Small
  • Kim N.

The scientist's contributions to the field have been recognized with honors such as the title of Fellow of the National Academy of Inventors, awarded in 2020.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

    Himisha Beltran;David S. Rickman;Kyung Park;Sung Suk Chae

  • Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

    Jennifer A. Locke;Emma S. Guns;Amy A. Lubik;Hans H. Adomat

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

    Meritxell Gironella;Mylène Seux;Min-Jue Xie;Carla Cano

  • The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

    Charles E Massie;Andy Lynch;Antonio Ramos-Montoya;Joan Boren

  • Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

    David A. Quigley;Ha X. Dang;Shuang G. Zhao;Paul Lloyd

  • Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    Rahul Aggarwal;Jiaoti Huang;Joshi J. Alumkal;Li Zhang

  • Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells

    Hsi‐Chin ‐C Wu;Jer‐Tsong ‐T Hsieh;Martin E. Gleave;Nicholas M. Brown

  • Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

    Elahe A. Mostaghel;Stephanie T. Page;Daniel W. Lin;Ladan Fazli

  • Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.

    Martin Gleave;Jer Tsong Hsieh;Chuan Gao;Andrew C. Von Eschenbach

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer ☆

    Michael A.S. Jewett;Kamal Mattar;Joan Basiuk;Christopher G. Morash

  • Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

    David J. Mulholland;Naoko Kobayashi;Marcus Ruscetti;Allen Zhi

  • Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer

    Arun A Azad;Stanislav V Volik;Alexander W Wyatt;Anne Haegert

  • Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

    Matti Annala;Matti Annala;Gillian Vandekerkhove;Daniel Khalaf;Sinja Taavitsainen

  • Antisense therapy for cancer.

    Martin E. Gleave;Brett P. Monia

  • The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation

    Gabriel Leprivier;Marc Remke;Marc Remke;Barak Rotblat;Adrian Dubuc

  • Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

    M E Gleave;M Elhilali;Y Fradet;I Davis

  • Aggressive Variants of Castration-Resistant Prostate Cancer

    Himisha Beltran;Scott A. Tomlins;Ana M. Aparicio;Vivek K Arora

Frequent Co-Authors

Ladan Fazli
Ladan Fazli University of British Columbia
Amina Zoubeidi
Amina Zoubeidi University of British Columbia
Kim N. Chi
Kim N. Chi BC Cancer Agency
Colleen C. Nelson
Colleen C. Nelson Queensland University of Technology
Yuzhuo Wang
Yuzhuo Wang University of British Columbia
Colin Collins
Colin Collins University of British Columbia
Alexander W. Wyatt
Alexander W. Wyatt University of British Columbia
Daniel W. Lin
Daniel W. Lin University of Washington
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn't always require following the traditional pathway to an MD. There are several flexible and online options available to students who wish to advance their healthcare careers. For registered nurses, rn to bsn programs offer an accessible route to earning a Bachelor of Science in Nursing, sometimes even without on-site clinical requirements.

If you're interested in achieving the highest level in nursing, pursuing the shortest dnp program online can fast-track your journey to a Doctor of Nursing Practice. There are also easy dnp programs available for nurses looking for a less intensive route. These programs often offer greater flexibility and efficiency than traditional on-campus options.

For those starting out, fast track lpn programs provide a way to quickly enter the workforce as a Licensed Practical Nurse. Whether you aim to build a foundational career or advance your qualifications, these online degrees and pathways can help you achieve your goals faster and more conveniently.

Best Scientists Citing Martin E. Gleave

Trending Scientists